Belle Mead, NJ, United States of America

Ian Ross Harris

This inventor holds 22 USPTO granted patents, plus 8 CIPO patents and 17 EPO patents, primarily in Postpartum Cell Therapy. Top assignees: Depuy Synthes Products, Inc., Ethicon, Gmbh, Advanced Technologies and Regenerative Medicine, LLC. Active years: 2003-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian Ross Harris. Retrieved from https://idiyas.com/inventor/ian-ross-harris

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22

% Patents Active = 50.0

CIPO Patents = 8

EPO Patents = 17 (Patent Applications = 8)

Average Co-Inventor Count = 5.5

ph-index = 12

Forward Citations = 648(Granted Patents)

Location History:

Radnor, PA (US) (2012 - 2019)
Belle Mead, NJ (US) (2003 - 2021)
Spring House, PA (US) (2021)

Company Filing History:

13 out of 2,758

Depuy Synthes Products, Inc.

Advanced Technologies and Regenerative Medicine, LLC

patents

4. 1 out of 2,101

Janssen Pharmaceutica Nv

patents

Years Active: 2003-2021

Loading Chart...

Areas of Expertise:

Postpartum Cells

Tissue Regeneration

Neural Repair

Cartilage Repair

Umbilical Cord Tissue

Placental Tissue

Cell Harvesting

Soft Tissue Repair

Heart Disease Treatment

Hydrogels

Smooth Muscle Cells

Retinitis Pigmentosa

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11191789 - Cartilage and bone repair and regeneration using postpartum-derived cells (2021-12-07),

2. 11000554 - Postpartum cells derived from placental tissue, and methods of making and using the same (2021-05-11),

3. 10500234 - Postpartum cells derived from umbilical cord tissue, and methods of making and using the same (2019-12-10),

4. 10383898 - Postpartum cells derived from placental tissue, and methods of making and using the same (2019-08-20),

5. 10220059 - Postpartum cells derived from placental tissue, and methods of making and using the same (2019-03-05),

6. 10195233 - Postpartum cells derived from placental tissue, and methods of making and using the same (2019-02-05),

7. 9717763 - Postpartum cells derived from umbilical cord tissue, and methods of making and using the same (2017-08-01),

8. 9579351 - Postpartum cells derived from placental tissue, and methods of making and using the same (2017-02-28),

9. 9572840 - Regeneration and repair of neural tissue using postpartum-derived cells (2017-02-21),

10. 9498501 - Postpartum cells derived from umbilical cord tissue, and methods of making and using the same (2016-11-22),

11. 8815587 - Postpartum cells derived from umbilical tissue and methods of making and using the same (2014-08-26),

12. 8703121 - Postpartum-derived cells for use in treatment of disease of the heart and circulatory system (2014-04-22),

13. 8658152 - Regeneration and repair of neural tissue using postpartum-derived cells (2014-02-25),

14. 8318483 - Postpartum cells derived from umbilical cord tissue, and methods of making and using the same (2012-11-27),

15. 8277796 - Regeneration and repair of neural tissue using postpartum-derived cells (2012-10-02),

Title: Innovations by Ian Ross Harris in Cartilage and Bone Repair

Introduction

Ian Ross Harris, a prolific inventor based in Belle Mead, NJ, has made significant contributions to the field of regenerative medicine with a remarkable portfolio of 22 patents. His work focuses on harnessing the potential of postpartum-derived cells for therapeutic applications, particularly in cartilage and bone repair.

Latest Patents

Among his latest innovations, Ian Ross Harris has developed methods for cartilage and bone repair and regeneration using postpartum-derived cells. This invention details the isolation of cells derived from postpartum tissue and their differentiation into chondrogenic or osteogenic cells. The invention also encompasses cultures and compositions of these cells, presenting numerous applications in research, diagnostics, and therapies aimed at treating bone and cartilage conditions. Additionally, he has designed methods for utilizing cells derived from postpartum placenta, which also include a wide range of applications in various therapeutic areas.

Career Highlights

Ian has had an impressive career, contributing his expertise to prominent companies such as DePuy Synthes Products, Inc. and Ethicon, GmbH. His work in these organizations has solidified his position as an innovator in medical technology and regenerative therapies.

Collaborations

Throughout his journey, Ian has collaborated with esteemed colleagues, including Alexander M. Harmon and Anna Gosiewska. These associations have fostered a dynamic exchange of ideas and have propelled his inventive projects toward successful outcomes.

Conclusion

Ian Ross Harris exemplifies the spirit of innovation in the field of regenerative medicine. Through his groundbreaking patents and collaborations, he continues to pave the way for new therapeutic strategies that leverage the potential of postpartum-derived cells, ultimately enhancing patient care in the treatment of orthopedic conditions.

Profile summary based on public USPTO records.